These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35144622)

  • 1. Pulmonary vascular inflammation with fatal coronavirus disease 2019 (COVID-19): possible role for the NLRP3 inflammasome.
    Paul O; Tao JQ; West E; Litzky L; Feldman M; Montone K; Rajapakse C; Bermudez C; Chatterjee S
    Respir Res; 2022 Feb; 23(1):25. PubMed ID: 35144622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Inflammation in Lungs of Patients with Fatal Coronavirus Disease 2019 (COVID-19): Possible Role for the NLRP3 Inflammasome.
    Paul O; Tao JQ; West E; Litzky L; Feldman M; Montone K; Rajapakse C; Bermudez C; Chatterjee S
    Res Sq; 2021 Sep; ():. PubMed ID: 34494018
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammasome formation in the lungs of patients with fatal COVID-19.
    Toldo S; Bussani R; Nuzzi V; Bonaventura A; Mauro AG; Cannatà A; Pillappa R; Sinagra G; Nana-Sinkam P; Sime P; Abbate A
    Inflamm Res; 2021 Jan; 70(1):7-10. PubMed ID: 33079210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in the relationship between NLRP3 inflammasome and lung injury in COVID-19].
    Ren Z; Che P; Li Z; Mo M; Zhang S; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):844-850. PubMed ID: 34533131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Inflammation in Lungs of Patients with Fatal Coronavirus Disease 2019 (COVID-19) Infection: Possible role for the NLRP3 inflammasome.
    Paul O; Tao JQ; Litzky L; Feldman M; Montone K; Rajapakse C; Bermudez C; Chatterjee S
    medRxiv; 2021 Mar; ():. PubMed ID: 33791735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19.
    de Sá KSG; Amaral LA; Rodrigues TS; Caetano CCS; Becerra A; Batah SS; Lopes FT; de Oliveira IM; Lopes LS; Almeida L; Mota CM; Oliveira S; Wada DT; Koenigkam-Santos M; Martins RB; Rosales RRC; Arruda E; Fabro AT; Zamboni DS
    PLoS Pathog; 2024 Jun; 20(6):e1012222. PubMed ID: 38838044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bibliometric analysis of NLRP3 inflammasome in acute lung injury/acute respiratory distress syndrome from 2010 to 2021.
    Xiao Z; Hu S; Xu W; Wang S; Mo W; Deng H; Wei J; Yang H; Zhou W; Li Q; Zhou H; Lv X
    Front Immunol; 2022; 13():1053658. PubMed ID: 36618363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases.
    Cama VF; Marín-Prida J; Acosta-Rivero N; Acosta EF; Díaz LO; Casadesús AV; Fernández-Marrero B; Gilva-Rodríguez N; Cremata-García D; Cervantes-Llanos M; Piniella-Matamoros B; Sánchez D; Del Rosario-Cruz L; Borrajero I; Díaz A; González Y; Pentón-Arias E; Montero-González T; Guillen-Nieto G; Pentón-Rol G
    J Neuroimmunol; 2021 Dec; 361():577728. PubMed ID: 34619427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice.
    Zeng J; Xie X; Feng XL; Xu L; Han JB; Yu D; Zou QC; Liu Q; Li X; Ma G; Li MH; Yao YG
    EBioMedicine; 2022 Jan; 75():103803. PubMed ID: 34979342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of mitochondrial ROS-NLRP3 inflammasome axis during two-hit mediated acute lung injury in mice.
    Puri G; Naura AS
    Free Radic Res; 2022 Jan; 56(1):1-16. PubMed ID: 35129032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIM2 deletion alleviates lipopolysaccharide (LPS)-induced respiratory distress syndrome (ARDS) by suppressing NLRP3 inflammasome.
    Wang F; Xu L; Dong G; Zhu M; Liu L; Wang B
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1419-1426. PubMed ID: 33333710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19.
    Saeedi-Boroujeni A; Mahmoudian-Sani MR; Nashibi R; Houshmandfar S; Tahmaseby Gandomkari S; Khodadadi A
    Immunopharmacol Immunotoxicol; 2021 Jun; 43(3):247-258. PubMed ID: 34015982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Borago officinalis on the signaling pathway of the NLRP3 inflammasome complex, TLR4 and some inflammatory cytokines in type II diabetic patients with acute respiratory distress syndrome.
    Yue Y; Jin F; Yue X
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):178-183. PubMed ID: 34933712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19.
    Houshmandfar S; Saeedi-Boroujeni A; Rashno M; Khodadadi A; Mahmoudian-Sani MR
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2187-2195. PubMed ID: 34590186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS).
    Messaoud-Nacer Y; Culerier E; Rose S; Maillet I; Rouxel N; Briault S; Ryffel B; Quesniaux VFJ; Togbe D
    Cell Death Dis; 2022 Mar; 13(3):269. PubMed ID: 35338116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS.
    Nabavi SF; Sahebnasagh A; Shahbazi A; Nabavi SM; Azimi S; Kashani MK; Habtemariam S; Rahmani M; Badiee M; Hashemi J; Saghafi F; Amini K; Azimi M; Rezabakhsh A
    Curr Med Chem; 2023; 30(12):1406-1419. PubMed ID: 36065926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells.
    Jäger B; Seeliger B; Terwolbeck O; Warnecke G; Welte T; Müller M; Bode C; Prasse A
    Front Immunol; 2021; 12():642855. PubMed ID: 33968032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
    Rodrigues TS; de Sá KSG; Ishimoto AY; Becerra A; Oliveira S; Almeida L; Gonçalves AV; Perucello DB; Andrade WA; Castro R; Veras FP; Toller-Kawahisa JE; Nascimento DC; de Lima MHF; Silva CMS; Caetite DB; Martins RB; Castro IA; Pontelli MC; de Barros FC; do Amaral NB; Giannini MC; Bonjorno LP; Lopes MIF; Santana RC; Vilar FC; Auxiliadora-Martins M; Luppino-Assad R; de Almeida SCL; de Oliveira FR; Batah SS; Siyuan L; Benatti MN; Cunha TM; Alves-Filho JC; Cunha FQ; Cunha LD; Frantz FG; Kohlsdorf T; Fabro AT; Arruda E; de Oliveira RDR; Louzada-Junior P; Zamboni DS
    J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33231615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.